Company intelligence / Profile preview

Anhui Xinrun Pharmaceutical

Anhui, China

Ownership: Private
Development stage: Other

Overview

Anhui Xinrun Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company established in 2022 and based in Anhui Province. The company specializes in the development and clinical evaluation of pharmaceutical products, with a current focus on respiratory health. Its lead program involves the development of an acetylcysteine oral solution, which is currently undergoing bioequivalence studies in China. As a private entity, Anhui Xinrun Pharmaceutical is dedicated to advancing its pipeline of generic and innovative formulations to address unmet medical needs in the respiratory therapeutic area.

Therapeutic areas: Pulmonology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Anhui Xinrun Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Anhui Xinrun Pharmaceutical.

Explore the full profile